AA
WST icon

Ancora Advisors’s West Pharmaceutical WST Stock Holding History

Ancora Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.8K Buy
71
+6
+9% +$1.49K ﹤0.01% 1579
2025
Q4 		$17.9K Buy
65
+64
+6,400% +$17.5K ﹤0.01% 1599
2025
Q3 		$262 Hold
1
– – ﹤0.01% 1883
2025
Q2 		$219 Buy
+1
New +$214 ﹤0.01% 1892
2025
Q1 		– Sell
-1
Closed -$328 – 1905
2024
Q4 		$328 Buy
+1
New +$315 ﹤0.01% 1703
2024
Q2 		– Sell
-3
Closed -$1.17K – 1935
2024
Q1 		$1.17K Hold
3
– – ﹤0.01% 1612
2023
Q4 		$1.04K Hold
3
– – ﹤0.01% 1542
2023
Q3 		$1.11K Hold
3
– – ﹤0.01% 1555
2023
Q2 		$1.13K Buy
+3
New +$1.07K ﹤0.01% 1552

Other funds holding WST

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $61.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return